Atlas Trials

Determine the Effect of AZD3161,Injected Intradermally, on Quantitative Sensory Testing Variables in Normal and Ultraviolet-C (UVC) Exposed Skin in Healthy Volunteers

Clinical trial NCT01240148 · COMPLETED

Trial details

NCT number
NCT01240148
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Peripheral Neuropathic PainNociceptive Pain
Start date
2010-12-01
Primary completion
2011-03-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.